Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Decreases By 48.2%

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 415,800 shares, a drop of 48.2% from the February 28th total of 803,100 shares. Based on an average daily trading volume, of 1,625,800 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.0% of the shares of the company are short sold.

Bayer Aktiengesellschaft Stock Performance

Shares of OTCMKTS BAYRY opened at $6.15 on Friday. The stock has a market cap of $24.15 billion, a price-to-earnings ratio of -23.63 and a beta of 1.02. Bayer Aktiengesellschaft has a 12 month low of $4.79 and a 12 month high of $8.58. The company has a 50 day simple moving average of $5.94 and a two-hundred day simple moving average of $6.12. The company has a current ratio of 1.32, a quick ratio of 0.81 and a debt-to-equity ratio of 1.19.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.